The US centers for the control and prevention of diseases as well as the Food and Drug Administration took part in a meeting of the World Health Organization to discuss the composition of the flu vaccine, an official from the UN agency said on Friday.
President Donald Trump began the 12-month retreat for the United States to leave the WHO on the first day in office in January, and has since monitored dismantling of US foreign assistance that has achieved health programs worldwide.
“We hope that the break at work we take with the USA is temporary and hope that we can resonate in the coming weeks in full,” said Maria van Kerkhove, director of the Epidemic and Pandemic willingness and prevention of WHO.
“There is information that emerges from the US Agriculture Ministry on the animal side. So I would like to be very clear that the USA still contributes to it,” said Kerkhove.
The comments came on the edge of an event in which the WHO announced its recommendations for the composition of influenza vaccines for 2025-2026 in the northern hemisphere.
The global health authority has recommended that vaccines contain updated H3N2 strains that reflect the composition recommended for the southern hemisphere.
It was also recommended to contain two additional tribes of bird flu viruses, partly in response to a human case that was demonstrated in Australia last year.
A new report by three doctors says that the continued post -infectious cough that so many Canadians are experienced this winter are most often solved over time.
Despite the more extensive withdrawal of the WHO, the United States did not end the Pan American Health Organization (PAHO), the specialized health authority for America and the WHO regional office for America.
However, disorders were reported in the US vaccine assemblies in the United States after Robert F. Kennedy Jr. took over the head of the Department of Health and Human Services in the early this month.
